Basiliximab Injection Shortage
Last Updated: July 23, 2024
Status: Current
Products Affected - Description
-
- Simulect injection, Novartis, 10 mg, vial, 1 count, NDC 00078-0393-61
- Simulect injection, Novartis, 20 mg, vial, 1 count, NDC 00078-0331-84
Reason for the Shortage
-
- Novartis has Simulect on shortage due to manufacturing delays.
Available Products
-
- There is insufficient supply for usual ordering
Estimated Resupply Dates
-
- Novartis has 10 mg and 20 mg vials on allocation.
Updated
Created July 23, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.